Covid-19 roundup: US to pay $725M for Eli Lilly's new mAb, if authorized; WHO chief scientist says more variants are coming
Eli Lilly had a big day in the Washington, DC area yesterday. After getting pummeled at an adcomm for submitting a cancer drug candidate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
